Nouvelles

Découvrez les dernières nouvelles et les développements en IA et en apprentissage automatique dans le domaine de la thérapie guidée par imagerie (TGI) au Canada.

INOVAIT et le gouvernement du Canada annoncent les bénéficiaires du Fonds pilote d’INOVAIT dont l’objectif est de favoriser les progrès en thérapie guidée par imagerie et en intelligence artificielle

INOVAIT et le gouvernement du Canada annoncent les bénéficiaires du Fonds pilote d’INOVAIT dont l’objectif est de favoriser les progrès en thérapie guidée par imagerie et en intelligence artificielle

INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to announce the latest recipients of its Pilot Fund. This competitive funding program is awarded to compelling medical technology projects that harness the transformative power of AI, machine learning, and big data analytics in IGT to advance medical innovation and streamline care.

Nouvelles du réseau

Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging

Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging

Tenomix, an image-guided diagnostic company based out of Western University’s BioNext Medtech Incubator, recently celebrated a significant milestone with an oversubscribed all-Canadian $2.14M funding round. Established in 2021 by four alums of WORLDiscoveries’ Medical Innovation Fellowship program at Western University, Tenomix is transforming cancer staging, particularly in colorectal cancer, with its innovative approach.

PulseMedica is laser-focused on tackling vitreoretinal diseases

PulseMedica is laser-focused on tackling vitreoretinal diseases

The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.

Série de conférences sur la TGI

Regulating AI in Image-Guided Therapy

Suivre INOVAIT sur les médias sociaux

Le Réseau dans la presse

Logo for Canadian Healthcare Technology Magazine
The logo for the Financial post
The logo for Yahoo Finance
The logo for betakit
The logo for The Record